Owlet Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $3.35
- Today's High:
- $3.62
- Open Price:
- $3.51
- 52W Low:
- $2.5214
- 52W High:
- $22.68
- Prev. Close:
- $3.41
- Volume:
- 7623
Company Statistics
- Market Cap.:
- $29.08 million
- Book Value:
- -3.236
- Revenue TTM:
- $53.14 million
- Operating Margin TTM:
- -113.35%
- Gross Profit TTM:
- $23.30 million
- Profit Margin:
- -111.4%
- Return on Assets TTM:
- -47.31%
- Return on Equity TTM:
- -901.15%
Company Profile
Owlet Inc had its IPO on 2020-11-05 under the ticker symbol OWLT.
The company operates in the Healthcare sector and Medical Devices industry. Owlet Inc has a staff strength of 106 employees.
Stock update
Shares of Owlet Inc opened at $3.51 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $3.35 - $3.62, and closed at $3.58.
This is a +4.99% increase from the previous day's closing price.
A total volume of 7,623 shares were traded at the close of the day’s session.
In the last one week, shares of Owlet Inc have increased by +4.37%.
Owlet Inc's Key Ratios
Owlet Inc has a market cap of $29.08 million, indicating a price to book ratio of 17.2811 and a price to sales ratio of 1.343.
In the last 12-months Owlet Inc’s revenue was $53.14 million with a gross profit of $23.30 million and an EBITDA of $-58990000. The EBITDA ratio measures Owlet Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Owlet Inc’s operating margin was -113.35% while its return on assets stood at -47.31% with a return of equity of -901.15%.
In Q2, Owlet Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 28.7%.
Owlet Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-7.69 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Owlet Inc’s profitability.
Owlet Inc stock is trading at a EV to sales ratio of 1.3114 and a EV to EBITDA ratio of -0.8837. Its price to sales ratio in the trailing 12-months stood at 1.343.
Owlet Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $57.26 million
- Total Liabilities
- $48.38 million
- Operating Cash Flow
- $-11000.00
- Capital Expenditure
- $11000
- Dividend Payout Ratio
- 0%
Owlet Inc ended 2024 with $57.26 million in total assets and $0 in total liabilities. Its intangible assets were valued at $57.26 million while shareholder equity stood at $-27316000.00.
Owlet Inc ended 2024 with $0 in deferred long-term liabilities, $48.38 million in other current liabilities, 1000.00 in common stock, $-243092000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $24.75 million and cash and short-term investments were $24.75 million. The company’s total short-term debt was $13,380,000 while long-term debt stood at $2.00 million.
Owlet Inc’s total current assets stands at $51.75 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $12.98 million compared to accounts payable of $22.76 million and inventory worth $12.39 million.
In 2024, Owlet Inc's operating cash flow was $-11000.00 while its capital expenditure stood at $11000.
Comparatively, Owlet Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $3.58
- 52-Week High
- $22.68
- 52-Week Low
- $2.5214
- Analyst Target Price
- $15
Owlet Inc stock is currently trading at $3.58 per share. It touched a 52-week high of $22.68 and a 52-week low of $22.68. Analysts tracking the stock have a 12-month average target price of $15.
Its 50-day moving average was $4.29 and 200-day moving average was $5.51 The short ratio stood at 11.88 indicating a short percent outstanding of 0%.
Around 759.6% of the company’s stock are held by insiders while 5190.7% are held by institutions.
Frequently Asked Questions About Owlet Inc
Similar Industry Stocks (Medical Devices)
Most Active
Top Gainers
Top Losers
About
Owlet, Inc. operates as a digital parenting platform in the United States. The company’s platform focuses on giving real-time data and insights to parents. It offers smart monitoring products, which includes Dream Sock accompanying Owlet Dream App allows parents to view their baby’s sleep quality indicators, such as waking, heart rate, and movement; and the Dream Sock Plus based on same core technology as the Dream Sock, which is designed to grow with the children from new born to five years through an expanded fabric sock sets primarily for the U.S. and Canadian markets. The company also provides Smart Sock, an intelligent baby monitor to track an infant’s oxygen levels, heart rate, and sleep trends, which offers parents to view their baby’s heart rate and oxygen readings in real time through the Owlet application. In addition, it offers Owlet Cam 1, which includes a wide-angle view, sound and motion notifications, and background audio, as well as allows to stream secure and encrypted video to parents own private accounts on the application; and Cam 2, a second generation camera comprising the features included in the Cam 1 and provides predictive sleep technology, cry notifications, and video clips. The company also provides Monitor Duo and Dream Duo, which includes Sock Monitor offerings with high-definition video; and Owlet’s accessories comprising Owlet Sleeper features a full-length zipper for easy access during late night changes, and the Owlet Travel Case, which provides travel and extra accident protection for Owlet sock products. Further, its monitoring and health notification pipeline includes Health Notifications, an over-the-counter offering software as a medical device; and Owlet BabySat designed as a prescription monitoring device for infants to be utilized by various telehealth platforms, which primarily includes babies with diagnosed illnesses and health conditions. The company was founded in 2012 and is headquartered in Lehi, Utah.